{"id":15634,"date":"2020-04-02T09:56:20","date_gmt":"2020-04-02T13:56:20","guid":{"rendered":"https:\/\/medicarereport.org\/?p=15634"},"modified":"2020-04-02T09:56:20","modified_gmt":"2020-04-02T13:56:20","slug":"examining-medicare-part-d-policies-for-extended-supplies-of-medication","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=15634","title":{"rendered":"Examining Medicare Part D Policies for Extended Supplies of Medication"},"content":{"rendered":"<p>(By\u00a0Juliette Cubanski,\u00a0Karyn Schwartz, and Anthony Damico for Kaiser Family Foundation)<\/p>\n<p>In response to the ongoing coronavirus pandemic, current recommendations are for older adults to stay home and away from others. To prepare for extended stays at home, the Centers for Disease Control and Prevention (CDC) recommends gathering extra supplies, including prescription medicines. Some patients may encounter difficulty in doing so, however, as a result of their health plan\u2019s \u2018refill too soon\u2019 restrictions, which block coverage for a prescription that is being refilled early. For example, a plan may have a policy of not allowing refills of 30-day prescriptions until at least three weeks after the prescription was last filled.\u00a0 Continue reading <a href=\"https:\/\/www.kff.org\/medicare\/issue-brief\/examining-medicare-part-d-policies-for-extended-supplies-of-medication\/\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/07\/Kaiser-Family-Foundation.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-7499\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/07\/Kaiser-Family-Foundation.jpg\" alt=\"\" width=\"147\" height=\"138\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By\u00a0Juliette Cubanski,\u00a0Karyn Schwartz, and Anthony Damico for Kaiser Family Foundation) In response to the ongoing coronavirus pandemic, current recommendations are<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-15634","post","type-post","status-publish","format-standard","hentry","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15634","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15634"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15634\/revisions"}],"predecessor-version":[{"id":15635,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15634\/revisions\/15635"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15634"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15634"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}